Retired CFO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Oilbull, do you really think that a deal that was suppose to close over a year ago is still valid? The original deal was done when I think oil prices were $40. Now they are over $80. There is no deal. Arete Industries still hasn't paid the property taxes for the pipeline that were due last November. They are broke. These guys are all CONSULTANTS which means they have other real jobs. The only hope is they update the filings which will give this POS a short-term lift. And all knowing should do the smart thing and sell if that happens. IMO
I told Matt last night not to file the 10Q on Friday August 13th. I'm superstitious. LOL. So look for it on Monday the 16th or before the 13th.
You know another thing this says is about our Derivative Liability. That's a P&L hit each quarter. So now that this is August 4th I don't expect it to impact our 2Q Derivative Liability but it will impact our 3Q numbers. So we could actually be profitable in 3Q with this, or close to it. Just my opinion.
Well the excellent news in that statement to me is that he believes he will be generating cash by then to pay this debt.
I don't think it will take that long. I did ask Matt about the 8K and he sent me this that I could post on the subject.
You’re asking me to speculate on its effect, and I can’t do that.
But I can tell you, from our opinion, very good for CBAI and its shareholders. This obligation was under the “derivative liability” on our balance sheet for the last few years. This Liability now gets paid down over the next 12 months, making our balance sheet stronger. We took 36M warrants off the table. Interest is only for 6 months and payable in cash, not shares. We reduced the obligation by 300k. So I would say reducing obligation, removing warrant overhang, removing the derivative liability over the next 12 months, and only having interest paid in cash are all good for shareholders. This was a liability that needed to be paid, and it has been on our balance sheet for years now (again, under derivative liability), so it eventually had to be paid. “
Good move Locks.
I like whatever makes my savings account go up HUGE.
Maybe not in your timeframe but in my timeframe these prices are going to be stupid low. Right Mr Long?
I agree. He changed the wording for a reason. What would make us the most significant? Obviously, it has to be more than processing and storage which he has always said was going to be there core business. Interesting.
Not true. CBAI can still be the largest in the world. No doubt. Would just take some consolidation which over time is a natural ocurrense.
I believe there is something to it but don't know what. Time will tell.
Can you please provide a link? Thanks.
We would need a sugar Daddy.
Did he leave Vita 34 and BCBS?
And a BCBS executive. We went thru this when we were speculating on what German company Matt was buying. Mr. Neeson is a BCBS executive who sat on our Board and then became of the CEO of Vita 34. A company that BCBS owns 20% of and much of the rest is owned by "private investors". Vita 34 use to be a beneficial owner of CBAI due to the Corcell purchase but that was before the dilution. It could be Vita 34 that CSTI is buying for but just a guess. Has always seemed to me BCBS might want to consolidate there cord blood investments at some point. Time will tell.
I was wondering the same thing. Yes we closed at .0057 but I'm not sure how.
I think whoever CSTI is buying for is going to be our big boy toy when all is said and done.
Morning all. Holter, I think you're going to think you are rich by the end of this year. But not as rich as you will be by year-end 2011 if you don't sell. Matt's just getting warmed up.
I agree.
I heard there was something out there but I also saw a report recently that someone was working on muliplying stems and it was considered to be a breakthrough if it worked. So I'm not sure what is out there now really works that well.
As for the life expectancy of stored stems, I haven't seen anything that suggests they don't live forever. And I believe it takes a perfect stem match for regenerative medicine?
I watch it but it has gone down more than CBAI.
My take. All please let me know your thoughts.
From a purely product perspective, I see the storing of your cord blood as not just for possible use against disease, but a lifetime insurance policy for all kinds of stuff in the future. Obviously, the main argument today is to protect against certain diseases, and that could be a life saver.
Two questions that need an answer is for how long can these stems be stored safely and useful? And when will we have a method to increase the available stems since the cord blood provides a rather small amount?
So what if you stored your cord blood at birth, it lasts forever, can be mulitplied for uses, is a perfect match, why wouldn't you store it for $4,000 or so. One day soon those stems could save your life by fighting disease, or growing a new body part like a liver, kidney, finger, and on and on. If they last forever they are a perfect match for a lifetime. Not just eighteen years.
I have nine grandkids and didn't store a single one. Never even heard about the option until the middle of last year. Oh do I wish I had known. One of them might have been a match for me too and saved my life.
The only downside I see is the possibility that one day Doctors can obtain those same stems without needing a match. From within your current body. Otherwise and until then, this company is golden IMO. More people just need to understand.
On Stellacure, since we own 51% (which is a must for Matt), then we claim all (100%) of the revenue. And on Biocells, the ownership doesn't start until the closing so backdating anything is not possible.
The outsourcing didn't affect revenue and nor did the royalties. But with us processing inhouse, I expect our gross profit to be around 60%, up from around 50%. And the royalties ended March 2010 so we're done with them. However, we haven't paid them yet and if we end up not having to pay them that would improve the bottom line that quarter by at least $400K (when they reverse the accrual). The royalty is still legally being addressed but I think we win eventually.
I'm not so sure. Stellacure closed right at the end of the 1st quarter. Now this quarter we will have the full impact of there revenue which should contribute about $350K to the 2nd quarter number. One reason I say the 2nd quarter revenue will be up at least 50% over the 1st quarter.
Then we close Biocells the end of August so will have about one month of there revenue reflected in the 3Q numbers. Add that to the other stuff we're doing and the 4th quarter could be around $2M which would be more than double 2009's 4th quarter revenue. Maybe three times.
Well since we're all so hopeful this morning I'll add my two cents. First, Matt is back in Vegas. Second, during a recent email from him he stated "he needed to do something big" to get the share price up. Now he didn't say he had something big planned but he wouldn't tell me if he did anyway. But he knows he needs to do something big and he did say it. All I got.
As I have previously stated. The chances of a share buy back now are slim and none. We're not even cash flow positive yet much less profitable. Sorry.
You might better wear a cup just in case. LOL
I sure hope for your sake that shelf doesn't collapse.
Not really but he's been a regular for a while now. Sometimes he seems to sell but I think he's putting up a block to try to keep the price down. He's bought a bunch and you can't tell how often he goes up and hits the ask while sitting a little lower on the bid side. He would have to buy 250M before becoming a beneficial owner and having to file.
A market maker that has been sitting on or around the bid for weeks now. It appears it's an european based company so probably an european investor. Only if they accumulate at least 5% will we find out who the buyer is.
CSTI continues to slowly acquire shares.
Nope. Just checked. One was due 11/10/09 and the other due 5/10/10. Neither has been paid yet.
Yes. I watched it on TV. Very sad. I was so excited that we would be offering this child the safety of storing her cord blood for free thanks to Matt and Joe. A very sad story turned even sadder today.
I held off telling this story but now would like to share. I didn't ask if I could share so I hope it's OK with CBAI. A couple of weeks ago you may have heard that two Police Officers were killed in the line of duty in Tampa, FL. I live in Tampa and was very upset about the whole thing. One officer killed was married and his wife was nine months pregnant with there first child. Obviously for this particular officer it would be his one and only.
Knowing that both Matt (CEO) and Joe (COO) at one time lived in Tampa, I emailed them both and suggested they donate the storing of this precious childs cord blood. They agreed and I set off making contacts with the Tampa Police Department where I had some contacts. No doubt the offer of storing the childs cord blood for free went well up in the organization. Of course this was during the time the funeral was being planned which was a big event here.
A few days later I got a call back and the only answer they gave me was they would not be able to accept the generous offer. I assumed the baby had already arrived and they were just keeping it from the public for now. Today the sad news came.
Wife of slain officer delivers stillborn baby
Last Updated: Wednesday, July 21, 2010 More InfoPrevious stories
Fundraiser and donations for officers' families
TAMPA --
The wife of slain Tampa police officer Jeffrey Kocab has delivered a stillborn baby.
Sara Kocab delivered the couple's baby, Lilly Nicole, early Wednesday morning.
A police spokesperson said the family knew that the baby had an abnormality that could have resulted in a stillbirth, or, had the baby survived, a shortened life. The spokesperson said there is no medical treatment for the abnormality.
Kocab's husband, Jeffrey, was killed June 29. Investigators said he and his fellow officer, David Curtis, were shot to death during a routine traffic stop. Dontae Morris, 24, has been charged with their murders.
The spokesperson said the Kocab family wanted to thank the public for their support and prayers over the past few weeks.
Being well past April 20th when do you expect an announcement on this? I think you mentioned August earlier? Is there a date set in August yet?.
Sorry but I'm no expert on filing requirements. But IMO the chances of a buyback right now are slim and none. Until we have profits to use the only way we could do a buyback would be to borrow cash and we just got out of that problem last year thru dilution. That's my view.
I just heard on TV that Nevada has the highest unemployment rate in the Country. Another good reason for Harry Reid to help get us that contract. And I still think that new training program has something to do with the contract.
Morning all. Nite moved up to .0072. He is the critical player here so hope he stays there. Lets hope for a good week.
July 19th CEOcast Weekly Newsletter?
http://www.ceocast.com/(rn5lvy55t1vokonqlj53hg55)/index.aspx
Sunday, July 18 2010
Volume Alert: Shares of Cord Blood America, Inc. (OTCBB: CBAI), an umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, to families nationwide and internationally, surged more than 10% last week on five times average volume, after the company announced that all preliminary due diligence is now complete for the acquisition of a controlling interest in BioCells, Inc. BioCells is the second largest stem cell storage company in Argentina, with 12 locations throughout that nation of 40 million people, plus recent expansion into Uruguay and Paraguay. The company is also in the process of developing affiliationsin Peru, Colombia, Bolivia, Panama and Puerto Rico. BioCells reported annual revenues in 2009 of $1.2 million. A letter of intent had been signed by both companies for Cord Blood America to purchase a controlling interest in BioCells, before August 31, 2010. CBAI also also announced last week that it has begun its continuing education program for the nation's 2.9 million registered nurses on the value of cord blood collection as a potentially life-saving resource for treating serious diseases. Recently, the first two courses were held in Pennsylvania and West Virginia, with additional courses planned in various states in the upcoming months. The company is supporting the Mandatory Continuing Education Law, Act 58, by helping nurses take advantage of planned learning opportunities. Shares of CBAI closed out the week at $0.01.